These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 17625080)

  • 1. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.
    Gan CT; Holverda S; Marcus JT; Paulus WJ; Marques KM; Bronzwaer JG; Twisk JW; Boonstra A; Postmus PE; Vonk-Noordegraaf A
    Chest; 2007 Jul; 132(1):11-7. PubMed ID: 17625080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of epoprostenol and sildenafil on right ventricular function in hypoxic volunteers: a tissue Doppler imaging study.
    Pavelescu A; Naeije R
    Eur J Appl Physiol; 2012 Apr; 112(4):1285-94. PubMed ID: 21785860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.
    Borgdorff MA; Bartelds B; Dickinson MG; van Wiechen MP; Steendijk P; de Vroomen M; Berger RM
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H361-9. PubMed ID: 24878769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness.
    Stevens GR; Garcia-Alvarez A; Sahni S; Garcia MJ; Fuster V; Sanz J
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):378-87. PubMed ID: 22498327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.
    Chin KM; Kingman M; de Lemos JA; Warner JJ; Reimold S; Peshock R; Torres F
    Am J Cardiol; 2008 Jun; 101(11):1669-72. PubMed ID: 18489949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients.
    De Santo LS; Mastroianni C; Romano G; Amarelli C; Marra C; Maiello C; Galdieri N; Della Corte A; Cotrufo M; Caianiello G
    Transplant Proc; 2008; 40(6):2015-8. PubMed ID: 18675118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
    Cotrim C; Loureiro MJ; Miranda R; Almeida S; Almeida AR; Simões O; Cordeiro P; Carrageta M
    Cardiovasc Ultrasound; 2007 Dec; 5():50. PubMed ID: 18162132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular function in pulmonary hypertension.
    Amano H; Toyoda S; Arikawa T; Inami S; Otani N; Nishi Y; Kitagawa Y; Taguchi I; Abe S; Inoue T
    Heart Vessels; 2013 Jul; 28(4):505-9. PubMed ID: 23124961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
    Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
    Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
    Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol.
    Oikawa M; Kagaya Y; Otani H; Sakuma M; Demachi J; Suzuki J; Takahashi T; Nawata J; Ido T; Watanabe J; Shirato K
    J Am Coll Cardiol; 2005 Jun; 45(11):1849-55. PubMed ID: 15936618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension.
    Reesink HJ; Tulevski II; Marcus JT; Boomsma F; Kloek JJ; Vonk Noordegraaf A; Bresser P
    Ann Thorac Surg; 2007 Aug; 84(2):537-43. PubMed ID: 17643631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
    Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA
    Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension.
    Claessen G; La Gerche A; Wielandts JY; Bogaert J; Van Cleemput J; Wuyts W; Claus P; Delcroix M; Heidbuchel H
    Heart; 2015 Apr; 101(8):637-44. PubMed ID: 25686630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.
    Wilkins MR; Paul GA; Strange JW; Tunariu N; Gin-Sing W; Banya WA; Westwood MA; Stefanidis A; Ng LL; Pennell DJ; Mohiaddin RH; Nihoyannopoulos P; Gibbs JS
    Am J Respir Crit Care Med; 2005 Jun; 171(11):1292-7. PubMed ID: 15750042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.
    Lewis GD; Shah RV; Pappagianopolas PP; Systrom DM; Semigran MJ
    Circ Heart Fail; 2008 Nov; 1(4):227-33. PubMed ID: 19808296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.